Processa Pharmaceuticals (PCSA) vs Silo Pharma (SILO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Processa Pharmaceuticals is the larger company by market cap ($4.4 million vs $3.7 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PCSA | SILO |
|---|---|---|
| Share price | $1.56 | $1.71 |
| Market cap | $4.37M | $3.69M |
| 1-day change | -7.69% | -9.04% |
| EPS (TTM) | $-68.29 | $-2.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $72.10K |
| Revenue growth (YoY) | — | 0.00% |
| Net income (latest FY) | $-13.56M | $-4.23M |
| Gross margin | — | 38.57% |
| Operating margin | — | -5936.95% |
| Net margin | — | -5863.50% |
| 52-week high | $8.88 | $10.43 |
| 52-week low | $1.04 | $1.10 |
| Distance from 52-week high | -82.43% | -83.60% |
| Average volume | 79.50K | 65.47K |
| Shares outstanding | 2.80M | 2.16M |
| Employees | 12 | 3 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Processa Pharmaceuticals
PCSA stock →Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
About Silo Pharma
SILO stock →Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
PCSA vs SILO FAQ
Which is bigger, Processa Pharmaceuticals or Silo Pharma?
Processa Pharmaceuticals (PCSA) is larger, with a market capitalization of $4.37M compared with $3.69M for Silo Pharma (SILO).
Are Processa Pharmaceuticals and Silo Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.